Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients [0.03%]
质子治疗可降低中纵隔霍奇金淋巴瘤患者免疫细胞的有效剂量
Pierre Loap,Ludovic De Marzi,Justine Decroocq et al.
Pierre Loap et al.
Purpose: Effective dose to circulating immune cells (EDIC) is associated with survival in lung and esophageal cancer patients. This study aimed to evaluate the benefit of intensity-modulated proton therapy (IMPT) for EDIC...
Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy [0.03%]
有关直肠隔间剂在质子与光子治疗前列腺癌中的作用及降低放射毒性影响的回顾性分析
Vishal R Dhere,Subir Goyal,Jun Zhou et al.
Vishal R Dhere et al.
Purpose: Rectal toxicity after prostate cancer (PCa) radiation therapy (RT) may be greater with protons compared with photon intensity-modulated RT, perhaps due to lateral penumbra and end-of-range uncertainty. Rectal spa...
Dosimetric Comparison Between Proton and Photon Radiation Therapies for Pediatric Neuroblastoma [0.03%]
儿科神经母细胞瘤质子治疗与光子治疗的剂量比较研究
Alfredo Mirandola,Francesca Colombo,Francesca Cavagnetto et al.
Alfredo Mirandola et al.
Purpose: The aim of this study is to determine the most beneficial radiation treatment technique for pediatric patients with thoracic and abdominal neuroblastoma (NBL), through a dosimetric comparison between photon Volum...
Cone-Beam CT Images as an Indicator of QACT During Adaptive Proton Therapy of Extremity Sarcomas [0.03%]
锥形束CT作为四肢肉瘤适应性质子治疗期间QAT的指示指标
Nrusingh C Biswal,Baoshe Zhang,Elizabeth Nichols et al.
Nrusingh C Biswal et al.
Purpose: Periodic quality assurance CTs (QACTs) are routine in proton beam therapy. In this study, we tested whether the necessity for a QACT could be determined by evaluating the change in beam path length (BPL) on daily...
Changes in Intratumor Blood Flow After Carbon-Ion Radiation Therapy for Early-Stage Breast Cancer [0.03%]
早期乳腺癌碳离子放射治疗后的瘤内血流变化规律研究
Kenta Ohmatsu,Tokuhiko Omatsu,Noriyuki Okonogi et al.
Kenta Ohmatsu et al.
Purpose: This study aimed to quantify the changes in intratumoral blood flow after carbon-ion radiation therapy (CIRT) for early-stage breast cancer and analyze their clinical significance. ...
Proton beam therapy and dentofacial development in paediatric cancer patients: A scoping review [0.03%]
质子束治疗对儿童癌症患者牙颌面部发育的影响：系统综述
Emma Foster-Thomas,Marianne Aznar,Bernadette Brennan et al.
Emma Foster-Thomas et al.
Purpose: It is known that radiation to dentofacial structures during childhood can lead to developmental disturbances. However, this appears to be a relatively subordinated research subject. For this reason, this review a...
Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC [0.03%]
质子治疗与光子治疗局部晚期非小细胞肺癌的免疫剂量学研究
Jimmy S Patel,Neal S McCall,Matthew Thomas et al.
Jimmy S Patel et al.
Purpose: Emerging data have illuminated the impact of effective radiation dose to immune cells (EDIC) on outcomes in patients with locally advanced, unresectable non-small cell lung cancer (NSCLC) treated with intensity-m...
Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer [0.03%]
超超高分割调强质子治疗前列腺癌的剂量学特征分析
Robert W Gao,Jiasen Ma,Thomas M Pisansky et al.
Robert W Gao et al.
Purpose: To report clinical and dosimetric characteristics of 5-fraction stereotactic ablative radiotherapy (SABR) using intensity modulated proton therapy (IMPT) for localized prostate cancer. ...
Dose Evaluation in 2-Phase Method for Advanced Esophageal Cancer by Hybrid Irradiation Techniques [0.03%]
综合调强放疗技术治疗晚期食管癌序贯放化疗剂量学评估
Makoto Sasaki,Hiroyasu Tamamura,Yuji Tameshige et al.
Makoto Sasaki et al.
Purpose: In concurrent chemoradiotherapy for advanced esophageal cancer, a 2-phase method consisting of initial irradiation of a wide elective nodal region and boost irradiation of the primary lesion is commonly employed....
Factors Associated With and Characteristics of Patients Receiving Proton Therapy at the End of Life [0.03%]
生命终点患者接受质子治疗的相关因素及特征分析
Mina Bakhtiar,Anish A Butala,Eva E Berlin et al.
Mina Bakhtiar et al.
Purpose: To identify the characteristics, indications, and toxicities among patients receiving proton beam therapy (PBT) in the final year of life at an academic medical center. ...